TIMP1 and neoplasm: The effects of inhibiting serpinE2 in tumors are multifaceted: ERK signaling was lowered, CCL2 levels were decreased, a skewing of tumor-promoting M2-like macrophages towards the M1-like phenotype was observed, and the level of the protease inhibitor TIMP1 increased.